EUVIMEDEUVIMED entdecken
Crossref

Chemoproteomic Profiling Reveals that Anticancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3**

Bridget P Belcher, Paulo A Machicao, Binqi Tong, Emily Ho, Julia Friedli, Brian So, Helen Bui, Yosuke Isobe, Thomas J Maimone, Daniel K Nomura iD

ChemBioChem · 2023

DOI: 10.1002/cbic.202300111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2023. Verfasst von Bridget P Belcher und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of California-Berkeley, Berkeley, CA 94720, USA. Hauptthemen laut MEDLINE: Biological Products, Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: NIH HHS, NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chlorinated gymnastatin and dankastatin alkaloids derived from the fungal strain Gymnascella dankaliensis have been reported to possess significant anticancer activity but their mode of action is unknown. These members possess electrophilic functional groups that can might undergo covalent bond formation with specific proteins to exert their biological activity. To better understand the mechanism of action of this class of natural products, we mapped the proteome‐wide cysteine reactivity of the most potent of these alkaloids, dankastatin B, by using activity‐based protein profiling chemoproteomic approaches. We identified a primary target of dankastatin B in breast cancer cells as cysteine C65 of the voltage‐dependent anion‐selective channel on the outer mitochondrial membrane VDAC3. We demonstrated direct and covalent interaction of dankastatin B with VDAC3. VDAC3 knockdown conferred hypersensitivity to dankastatin B‐mediated antiproliferative effects in breast cancer cells, thus indicating that VDAC3 was at least partially involved in the anticancer effects of this natural product. Our study reveals a potential mode of action of dankastatin B through covalent targeting of VDAC3 and highlights the utility of chemoproteomic approaches in gaining mechanistic understanding of electrophilic natural products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsBreast NeoplasmsHumansFemaleCysteineMitochondriaMitochondrial Membrane Transport ProteinsVoltage-Dependent Anion ChannelsBenzopyrans

Stichwörter der Autor:innen

VDAC3activity-based protein profilingchemoproteomics, dankastatin Bgymnastatins, natural products

Substanzen

CysteineBiological ProductsMitochondrial Membrane Transport ProteinsVoltage-Dependent Anion Channelsdankastatin BBenzopyransVDAC3 protein, human

Autor:innen und Institutionen

  • Department of Chemistry, University of California-Berkeley, Berkeley, CA 94720, USA.
  • Novartis-Berkeley Translational Chemical Biology Institute, Berkeley, CA 94720, USA.
  • Innovative Genomics Institute, Berkeley, CA 94704, USA.
  • Department of Molecular and Cell Biology, University of California-Berkeley, Berkeley, CA 94720, USA.

ORCID-Profile: Daniel K Nomura

Förderung

  • NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • College of Chemistry, Jilin University

Zitieren

APA

Belcher, B. P., Machicao, P. A., Tong, B., Ho, E., Friedli, J., So, B., Bui, H., Isobe, Y., Maimone, T. J., & Nomura, D. K. (2023). Chemoproteomic Profiling Reveals that Anticancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3**. ChemBioChem. https://doi.org/10.1002/cbic.202300111

Vancouver

Belcher BP, Machicao PA, Tong B, Ho E, Friedli J, So B, et al. Chemoproteomic Profiling Reveals that Anticancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3**. ChemBioChem. 2023. doi:10.1002/cbic.202300111

BibTeX
@article{Belcher2023,
  author = {Belcher, Bridget P and Machicao, Paulo A and Tong, Binqi and Ho, Emily and Friedli, Julia and So, Brian and Bui, Helen and Isobe, Yosuke and Maimone, Thomas J and Nomura, Daniel K},
  title = {Chemoproteomic Profiling Reveals that Anticancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3**},
  journal = {ChemBioChem},
  year = {2023},
  doi = {10.1002/cbic.202300111}
}
Kostenlos starten →